We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Biomarkers in Acute Cardiac Care (BACC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02355457
Recruitment Status : Recruiting
First Posted : February 4, 2015
Last Update Posted : June 1, 2022
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf

Brief Summary:
The primary aim of the study is to investigate new cardiac biomarkers and algorithms to diagnose acute coronary syndrome in patients with suspected acute myocardial infarction.

Condition or disease
Acute Coronary Syndrome Myocardial Infarction Chest Pain

Detailed Description:

The primary aim of the study is to detect and evaluate new cardiac biomarkers, evaluate and improve acute coronary syndrome (ACS) risk scores, which takes into account clinical, gender specific, psycho-social and lifestyle-risk factors, protein patterns and genetic variability in addition to the classical risk factors with respect to the primary endpoint of acute myocardial infarction.

Secondary study aims are :

  • To provide estimates for the incidence of ACS in patients presenting with recent onset chest pain;
  • To provide accurate, quantifiable measures of precursors of ACS;
  • DNA, RNA, cells, and serum/plasma for comprehensive genetic, gene expression and proteomic studies
  • To explore the impact of ACS candidate genes on cardiovascular risk stratification by using genome-wide analyses and a biological systems approach;
  • To explore proteins relevant for ACS;
  • To allow the identification of new therapeutic targets;
  • To evaluate the impact of socio-economic factors on ACS and CAD risk.

Patients will be followed up during the hospital stay. Afterwards a telephone follow-up will take place after 30 days, 6, 24 and 48 months.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 4 Years
Official Title: Biomarkers in Acute Cardiac Care
Study Start Date : July 2013
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Suspected acute myocardial infarction
Patients with recent onset symptoms suggesting acute myocardial infarction

Primary Outcome Measures :
  1. Acute myocardial infarction as index event [ Time Frame: Months ]
    The primary endpoint of the study is acute myocardial infarction

Secondary Outcome Measures :
  1. AMI, Mortality, heart failure and quality of life [ Time Frame: Years ]
    The secondary endpoint of the study is mortality, heart failure, quality of life.

Biospecimen Retention:   Samples With DNA
blood samples, white blood cells.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients presenting with suspected myocardial infarction in the emergency department or the chest pain unit of the University Hospital Hamburg-Eppendorf.

Inclusion Criteria:

  • Symptoms suggestive of acute myocardial infarction
  • Ability to provide written informed consent in accordance with Good epidemiological Practice and local legislation
  • Individuals at least 18 years old

Exclusion Criteria:

- Insufficient knowledge of the German language (able to understand and write the German language)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02355457

Layout table for location contacts
Contact: Johannes T Neumann, MD 0049407410 ext 56800 j.neumann@uke.de
Contact: Nils Sörensen, MD 0049407410 ext 56800 n.soerensen@uke.de

Layout table for location information
Department of Cardiology, University Heart Center Hamburg Recruiting
Hamburg, Germany, 20246
Contact: Johannes Neumann, MD    0049407410 ext 56800    j.neumann@uke.de   
Sponsors and Collaborators
Universitätsklinikum Hamburg-Eppendorf
Layout table for investigator information
Principal Investigator: Johannes Neumann, MD UHZ
Principal Investigator: Nils Sörensen, MD UHZ
Additional Information:

Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, Anand A, Boeddinghaus J, Nestelberger T, Badertscher P, Mokhtari A, Pickering JW, Troughton RW, Greenslade J, Parsonage W, Mueller-Hennessen M, Gori T, Jernberg T, Morris N, Liebetrau C, Hamm C, Katus HA, Münzel T, Landmesser U, Salomaa V, Iacoviello L, Ferrario MM, Giampaoli S, Kee F, Thorand B, Peters A, Borchini R, Jørgensen T, Söderberg S, Sans S, Tunstall-Pedoe H, Kuulasmaa K, Renné T, Lackner KJ, Worster A, Body R, Ekelund U, Kavsak PA, Keller T, Lindahl B, Wild P, Giannitsis E, Than M, Cullen LA, Mills NL, Mueller C, Zeller T, Westermann D, Blankenberg S; COMPASS-MI Study Group. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. N Engl J Med. 2019 Jun 27;380(26):2529-2540. doi: 10.1056/NEJMoa1803377. Erratum in: N Engl J Med. 2022 Nov 3;387(18):1724.

Layout table for additonal information
Responsible Party: Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier: NCT02355457    
Other Study ID Numbers: PV4306
First Posted: February 4, 2015    Key Record Dates
Last Update Posted: June 1, 2022
Last Verified: May 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by Universitätsklinikum Hamburg-Eppendorf:
myocardial infarction
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Acute Coronary Syndrome
Chest Pain
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Neurologic Manifestations